Helix BioPharma Corp. Closes Second Tranche of Private Placement

    NEXT STORY
    Sandoz enters agreement for proposed trastuzumab biosimilar, currently in Phase III development, to treat selected HER2-positive cancer tumors
    PREV STORY
    Alimera Sciences Announces First Quarter 2019 Financial Results and Provides Corporate Overview
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Neon Therapeutics Announces Completion of Enrollment in Phase 1b NT-002 Clinical Trial of NEO-PV-01 in Metastatic Non-Small Cell Lung Cancer

    author_avatar
    NASDAQ Market News

    SHIRE LAUNCHES MYPKFIT(TM) FOR ADVATE® [ANTIHEMOPHILIC FACTOR (RECOMBINANT)] IN THE U.S.

    SHIRE LAUNCHES MYPKFIT(TM) FOR ADVATE® [ANTIHEMOPHILIC FACTOR (RECOMBINANT)] IN THE U.S. First and only ...

    author_avatar
    NASDAQ Market News

    Symphogen publishes discovery and pre-clinical data on first chicken-derived antibody to enter human clinical trials

    author_avatar
    NASDAQ Market News